Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC Should Study Competitive Impact Of “Authorized” Generics, Senators Say

Executive Summary

A bipartisan group of senators is asking the Federal Trade Commission to study the competitive impact of "authorized" generics

You may also be interested in...



Authorized Generics Noose Tightens With “Best Price” Proposal, FTC Study

The Federal Trade Commission's decision to study the practice of authorized generics could become moot if the marketing of such products by brand companies becomes financially unattractive due to a potential change in Medicaid "best price" reporting requirements

Authorized Generics Noose Tightens With “Best Price” Proposal, FTC Study

The Federal Trade Commission's decision to study the practice of authorized generics could become moot if the marketing of such products by brand companies becomes financially unattractive due to a potential change in Medicaid "best price" reporting requirements

Drug Safety Funding To Increase By $10 Mil. Under FDA Appropriations

The Agriculture Appropriations conference report approved by the House and Senate doubles the Administration's requested increase in drug safety funding for FDA to $10 mil

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045813

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel